Loading
AlzeCure Pharma AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest was filed 26 Aug 2025.
AlzeCure Pharma AB: what insiders have been doing
This page follows insider dealings at AlzeCure Pharma AB as filed with Finansinspektionen, a company from the Health Care sector. In the past year (18 October 2025 to 18 October 2026), 5 filings came from 5 insiders.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
There has been no open-market purchase by an insider of AlzeCure Pharma AB for at least a year. Filings reach the Finansinspektionen feed a median of 1 day after the trade. The regulation allows three business days to notify a trade (MAR article 19).
Compared with its exchange (886 companies, median 7 filings), a count of 5 filings is below the norm. Over the whole record (from 2021), the tally stands at 2 purchases and no sales.
Other companies in the same sector with recent insider buying flagged by our signals: MAIA Biotechnology, Inc. and Cooper Companies, Inc. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Insider Decl.
10
Thresholds
n/a
Buy Volume
€19,270
2 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleMartin Jönsson1 buy
Financial data
as of FY 2025FY ended December 2025 · cache
SEK 6.62
Analyst consensus
1 analysts0.00/5
SEK 13.00Target SEK 13.00(+96%)SEK 13.00
Income statement
EBITDA-SEK 46.1M
Net income-SEK 47.7M31.6% margin
Valuation
PER (trailing)22.1x
P/Book10.0x
Beta-0.11
Balance sheet & cash
Market capSEK 760.7M
Total debtSEK 2.6M
Free Cash Flow-SEK 34.6M
Debt / Equity2%
Profitability & ownership
ROE62.9%
ROA27.3%
% insiders39.6%
% institutions12.7%
Last declaration on 4 July 2026
Declarations10 total
184,914 shares@ SEK 1.310.029% mcap93.2% of flowBTA (betald tecknad aktie)ISIN SE0028850099FI:csv-cd6e11af1a52c2985dd2
327,406 shares@ SEK 1.310.051% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0028850099FI:csv-59693ac2b9bb4637ea6c
240,625 shares@ SEK 1.310.037% mcap20.2% of flowBTA (betald tecknad aktie)ISIN SE0028850099FI:csv-a68983a62b35da41f27c
194,940 shares@ SEK 1.310.030% mcap56.4% of flowBTA (betald tecknad aktie)ISIN SE0028850099FI:csv-ae89b39d48641cfdae04
177,275 shares@ SEK 1.310.026% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0028798975FI:csv-ece03a7e2fc9302981e3
8,067 shares@ SEK 2.190.0020% mcap6.8% of flowAktieISIN SE0025399124FI:A003R766-1
Canonical exit: 23 Nov 2025 (T+90)
55,624 shares@ SEK 2.200.014% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0025399132FI:A003R199-1
150,000 shares@ SEK 2.200.037% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0010133785FI:A003R169-1
568,030 shares@ SEK 2.200.14% mcap79.8% of flowBTA (betald tecknad aktie)ISIN SE0010133785FI:A003R016-1
20,000 shares@ SEK 8.9743.6% of flowAktieISIN SE0010133785FI:A001P627-1
Canonical exit: 19 Apr 2021 (T+90)
10 of 10 declarations
About AlzeCure Pharma AB
AlzeCure Pharma AB is a biopharmaceutical company focused on developing treatments for neurodegenerative diseases, particularly Alzheimer's disease. It is listed on the XSTO market.
